ATCvet code QJ54
Veterinary medical products classification subgroup
Pharmaceutical drug classification
| ATC code J: Antiinfectives for systemic use |
|---|
|
| Human only |
|
| ATCvet only |
|
| Other ATC codes |
ATCvet code QJ54 Antimycobacterials for intramammary use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System for veterinary medicinal products, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products for veterinary use.[1][2] Subgroup QJ54 is part of the anatomical group QJ Antiinfectives for systemic use.[3]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
QJ54A Drugs for mycobacterial infections
QJ54AB Antibiotics
- QJ54AB02 Rifampicin
- QJ54AB03 Rifamycin
References
- ^ "The ATCvet classification system" (PDF). European Medicines Agency. Retrieved 1 February 2020.
- ^ "ATCvet Code, ein Klassierungssystem für Tierarzneimittel" (in German). University of Zurich. Retrieved 1 February 2020.
- ^ "ATCvet Index 2022: code QJ54". WHO Collaborating Centre for Drug Statistics Methodology.
- v
- t
- e
| Rifamycins/ RNA polymerase inhibitor | |
|---|---|
| Antifolates/DSI | |
| ASA | |
| Topoisomerase inhibitors/ quinolones |
| Aminoglycosides | |
|---|---|
| Oxazolidone | |
| Polypeptide antibiotics |
| Peptidoglycan layer |
|
|---|---|
| Arabinogalactan layer |
|
| Mycolic acid layer |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
